Amneal Pharmaceuticals Inc [AMRX] stock is trading at $8.14, up 0.49%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AMRX shares have gain 4.23% over the last week, with a monthly amount glided 9.56%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Goldman upgraded its rating to Buy on March 08, 2021, and elevated its price target to $6.50. On December 14, 2020, upgrade upgraded it’s rating to Buy but maintained its price target of $5.50 on the stock. Barclays upgraded its rating to a Overweight and increased its price target to $6 on December 14, 2020. Goldman initiated its recommendation with a Sell and recommended $4 as its price target on July 27, 2020. Guggenheim upgraded its rating to Neutral for this stock on May 12, 2020. In a note dated December 12, 2019, Raymond James downgraded an Mkt Perform rating on this stock.
Amneal Pharmaceuticals Inc [AMRX] stock has fluctuated between $3.36 and $8.28 over the past year. Currently, Wall Street analysts expect the stock to reach $7 within the next 12 months. Amneal Pharmaceuticals Inc [NASDAQ: AMRX] shares were valued at $8.14 at the most recent close of the market. An investor can expect a potential drop of -14.0% based on the average AMRX price forecast.
Analyzing the AMRX fundamentals
Amneal Pharmaceuticals Inc [NASDAQ:AMRX] reported sales of 2.60B for the trailing twelve months, which represents a growth of 17.15%. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -12.4 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-44.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.09 points at the first support level, and at 8.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.19, and for the 2nd resistance point, it is at 8.24.
Ratios To Look Out For
For context, Amneal Pharmaceuticals Inc’s Current Ratio is 1.33. Also, the Quick Ratio is 0.82, while the Cash Ratio stands at 0.04. Considering the valuation of this stock, the price to sales ratio is 0.97.
Transactions by insiders
Recent insider trading involved BOYER ANDREW S, Executive Vice President, that happened on Aug 15 ’24 when 40225.0 shares were sold. Executive Vice President, BOYER ANDREW S completed a deal on Aug 14 ’24 to sell 22486.0 shares. Meanwhile, Executive Vice President Shah Nikita sold 100000.0 shares on Aug 14 ’24.
